CN101595101A - 喹诺酮羧酸、其衍生物及它们的制备方法和作为抗菌剂的用途 - Google Patents

喹诺酮羧酸、其衍生物及它们的制备方法和作为抗菌剂的用途 Download PDF

Info

Publication number
CN101595101A
CN101595101A CNA2008800031182A CN200880003118A CN101595101A CN 101595101 A CN101595101 A CN 101595101A CN A2008800031182 A CNA2008800031182 A CN A2008800031182A CN 200880003118 A CN200880003118 A CN 200880003118A CN 101595101 A CN101595101 A CN 101595101A
Authority
CN
China
Prior art keywords
substituted
unsubstituted
formula
compound
fluoroquinolone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2008800031182A
Other languages
English (en)
Chinese (zh)
Inventor
A·E·哈姆斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bausch and Lomb Inc
Original Assignee
Bausch and Lomb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch and Lomb Inc filed Critical Bausch and Lomb Inc
Publication of CN101595101A publication Critical patent/CN101595101A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CNA2008800031182A 2007-01-24 2008-01-11 喹诺酮羧酸、其衍生物及它们的制备方法和作为抗菌剂的用途 Pending CN101595101A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/626,397 2007-01-24
US11/626,397 US7632944B2 (en) 2007-01-24 2007-01-24 Quinolone carboxylic acids, derivatives thereof, and methods of making and using same

Publications (1)

Publication Number Publication Date
CN101595101A true CN101595101A (zh) 2009-12-02

Family

ID=39410211

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2008800031182A Pending CN101595101A (zh) 2007-01-24 2008-01-11 喹诺酮羧酸、其衍生物及它们的制备方法和作为抗菌剂的用途

Country Status (10)

Country Link
US (1) US7632944B2 (cg-RX-API-DMAC7.html)
EP (1) EP2114915A2 (cg-RX-API-DMAC7.html)
JP (1) JP2010516775A (cg-RX-API-DMAC7.html)
KR (1) KR20090118027A (cg-RX-API-DMAC7.html)
CN (1) CN101595101A (cg-RX-API-DMAC7.html)
AU (1) AU2008209416B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0806581A2 (cg-RX-API-DMAC7.html)
CA (2) CA2674543C (cg-RX-API-DMAC7.html)
MX (1) MX2009007413A (cg-RX-API-DMAC7.html)
WO (1) WO2008091752A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9180817B2 (en) 2010-01-25 2015-11-10 Mci (Mirror Controls International) Netherlands B.V. Exterior mirror unit, mirror support, method for assembly of an exterior mirror unit

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090054406A1 (en) * 2007-08-21 2009-02-26 Ward Keith W Compositions and Methods for Modulating Endophthalmitis Using Fluoroquinolones
US8415342B2 (en) * 2008-10-29 2013-04-09 Bausch & Lomb Incorporated Besifloxacin ophthalmic composition for the treatment or control of infection
BR122020021551B1 (pt) 2008-11-15 2021-09-21 Melinta Subsidiary Corp Composição farmacêutica antimicrobiana e seu uso
US8481526B2 (en) * 2009-03-25 2013-07-09 Bausch & Lomb Incorporated Fluoroquinolone carboxylic acid molecular crystals
US10167271B2 (en) 2015-01-28 2019-01-01 Mankind Pharma Ltd Fluoroquinolone carboxylic acid compounds and use thereof for the preparation of besifloxacin hydrochloride
CN107880023B (zh) * 2017-11-10 2021-02-19 西南大学 氟喹诺酮类胺基衍生物及其用途
CN112159355B (zh) * 2020-09-25 2022-06-24 西南大学 对氨基水杨酸氟喹诺酮类衍生物及其中间体、制备方法和应用
CN112159354B (zh) * 2020-09-25 2022-07-05 西南大学 对氨基水杨酸的氟喹诺酮类衍生物及其中间体、制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1086735A (en) * 1977-11-03 1980-09-30 John C. Danilewicz Piperidino-quinazolines
EP0230946A3 (en) 1986-01-20 1988-09-07 Kyorin Pharmaceutical Co., Ltd. Process for the preparation of quinolonecarboxylic acid derivatives
JPS63132885A (ja) 1986-11-25 1988-06-04 Hokuriku Seiyaku Co Ltd キノリン−3−カルボン酸誘導体
JPS63196580A (ja) 1987-02-09 1988-08-15 Hokuriku Seiyaku Co Ltd キノリン−3−カルボン酸誘導体
JPS63196579A (ja) 1987-02-09 1988-08-15 Hokuriku Seiyaku Co Ltd キノリン−3−カルボン酸誘導体
JP2613139B2 (ja) 1990-07-19 1997-05-21 エスエス製薬 株式会社 キノロンカルボン酸誘導体
TW222272B (cg-RX-API-DMAC7.html) 1992-05-26 1994-04-11 Ss Seiyaku Kk
US5527910A (en) 1992-12-30 1996-06-18 Cheil Foods & Chemicals, Inc. Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria
TW301607B (cg-RX-API-DMAC7.html) * 1993-03-09 1997-04-01 Takeda Pharm Industry Co Ltd
FR2706459B1 (fr) 1993-06-17 1995-08-04 Bouchara Sa Nouveaux dérivés quinoloniques, leur procédé d'obtention et les compositions pharmaceutiques qui en contiennent.
EP0931078B1 (en) * 1996-09-13 2006-11-15 Schering Corporation Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase
US6685958B2 (en) 2001-04-25 2004-02-03 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US6699492B2 (en) 1999-03-31 2004-03-02 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
JP4612301B2 (ja) * 2003-12-26 2011-01-12 広栄化学工業株式会社 1−アルキル−4−アミノメチルピペリジンの製造法
DE102004035203A1 (de) * 2004-07-21 2006-02-16 Bayer Healthcare Ag Substituierte Chinolone

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9180817B2 (en) 2010-01-25 2015-11-10 Mci (Mirror Controls International) Netherlands B.V. Exterior mirror unit, mirror support, method for assembly of an exterior mirror unit

Also Published As

Publication number Publication date
EP2114915A2 (en) 2009-11-11
JP2010516775A (ja) 2010-05-20
WO2008091752A3 (en) 2008-10-16
WO2008091752A2 (en) 2008-07-31
US20080176834A1 (en) 2008-07-24
US7632944B2 (en) 2009-12-15
CA2674543C (en) 2012-12-04
CA2674543A1 (en) 2008-07-31
AU2008209416B2 (en) 2013-05-09
MX2009007413A (es) 2009-07-17
CA2790690A1 (en) 2008-07-31
AU2008209416A1 (en) 2008-07-31
KR20090118027A (ko) 2009-11-17
BRPI0806581A2 (pt) 2014-05-06

Similar Documents

Publication Publication Date Title
US8227597B2 (en) Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
CA2674543C (en) Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
US7868021B2 (en) Antimicrobial quinolones, their compositions and uses
JPH054968A (ja) キノロンカルボン酸誘導体
US7019143B2 (en) Antimicrobial quinolones, their compositions and uses
JPH0145468B2 (cg-RX-API-DMAC7.html)
CN114957153B (zh) 一种qs抑制活性化合物、组合物及在制备抗菌制剂领域的应用
US8252783B2 (en) Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
JPH02191257A (ja) ベンゾヘテロ環化合物
KR930003611B1 (ko) 퀴놀론 카복실산 유도체의 제조방법
JPS6028978A (ja) 1,8−ナフチリジン誘導体
JPH06145167A (ja) 8−メトキシ−5−メチルキノリン−3−カルボン酸誘導体
JP2761566B2 (ja) ピリドンカルボン酸化合物
JPH0366688A (ja) 1,4―ジヒドロ―4―オキソナフチリジン化合物
CN116768770A (zh) 二芳基硫脲类化合物及其应用
JPS6233188A (ja) ベンゾヘテロ環化合物
JPWO2002018344A1 (ja) 新規なエステル又はアミド誘導体
KR20030081762A (ko) 플루오로피롤리딘 치환체를 포함하는 퀴놀린 카르복실산유도체 및 그의 제조방법
CS250698B2 (cs) Způsob výroby l,4-dihydro-4-oxonaftyridinových derivátů
CN108864083A (zh) 一类具有抗癌活性的氨基取代吲嗪类化合物及其衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20091202